BioNTech Clocked Massive Q1 Revenue Growth; Estimates COVID-19 Vaccine Revenues Of €12B
May 10, 2021 at 10:00 AM EDT
BioNTech SE reports Q1 FY21 revenues of €2.05 billion compared to €27.7 million a year ago. The increase was mainly due to rapidly increasing the supply of COVID-19 vaccine worldwide.
